EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Potential of germanium-based compounds in coronavirus infection

Violetta Narokha, Iryna Nizhenkovska, Olena Kuznetsova

Acta Pharmaceutica · 01.06.2022 · 72 (2) · 245-258

DOI: 10.2478/acph-2022-0016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica, online erschienen am 30.12.2021. Verfasst von Violetta Narokha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biological and Toxicological Chemistry Faculty of Pharmacy, Bogomolets National Medical University Kyiv, Ukraine. Hauptthemen laut MEDLINE: COVID-19, Germanium. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first germanium compounds which exhibited immunomodulatory and antiviral effects were sesquioxane-type germanates. To date, more than a dozen compounds containing germanium have been synthesized and are being actively studied. They include germanium carboxylates and citrates, complexes of germanium with resveratrol, daphnetin, mangiferin, chrysin, quercetin, ascorbic and nicotinic acids, amino acids, gamma-lactones, germanium-containing spirulina, yeast and others. Germanium-based compounds have shown the ability to influence the replication of various DNA/RNA viruses, stimulate the body’s natural resistance, prevent the development of metabolic intoxication of various origin, increase the efficacy of vaccines, and prevent the development of excessive accumulation of reactive oxygen species, which plays a decisive role in the development of inflammatory response caused by a viral infection. It seems reasonable to say that germanium-based complex compounds effectively contribute to the preservation of high--energy bonds in the form of ATP, optimize the activity of metabolic processes by re-oxygenation, and exhibit antimicrobial activity. The purpose of this review is to summarize the pharmacological potential of various germanium-based compounds studied nowadays, taking into account their mechanisms of action, and to analyze their prospects in the development of integrated approaches in the prevention and treatment of SARS-CoV-2 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19GermaniumHumansSARS-CoV-2Antiviral AgentsQuercetin

Stichwörter der Autor:innen

COVID-19SARS-CoV-2germaniumorganic germanium

Substanzen

GermaniumAntiviral AgentsQuercetin

Autor:innen und Institutionen

  • Department of Pharmaceutical Biological and Toxicological Chemistry Faculty of Pharmacy, Bogomolets National Medical University Kyiv, Ukraine.

Zitieren

APA

Narokha, V., Nizhenkovska, I., & Kuznetsova, O. (2022). Potential of germanium-based compounds in coronavirus infection. Acta Pharmaceutica, 72(2), 245-258. https://doi.org/10.2478/acph-2022-0016

Vancouver

Narokha V, Nizhenkovska I, Kuznetsova O. Potential of germanium-based compounds in coronavirus infection. Acta Pharmaceutica. 2022;72(2):245-258. doi:10.2478/acph-2022-0016

BibTeX
@article{Narokha2022,
  author = {Narokha, Violetta and Nizhenkovska, Iryna and Kuznetsova, Olena},
  title = {Potential of germanium-based compounds in coronavirus infection},
  journal = {Acta Pharmaceutica},
  year = {2022},
  volume = {72},
  number = {2},
  pages = {245--258},
  doi = {10.2478/acph-2022-0016}
}
Kostenlos starten →